Quarraisha Abdool Karim

Quarraisha Abdool Karim publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Quarraisha Abdool Karim sits on this spectrum.

Quarraisha Abdool Karim D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Quarraisha Abdool Karim sits on this spectrum.

Research.com Recognitions

• 2015 - Fellow, The World Academy of Sciences
• 2014 - Member of the National Academy of Medicine (NAM)
• Fellow of the Royal Society of South Africa

Best Publications

• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

  Quarraisha Abdool Karim;Salim S. Abdool Karim;Salim S. Abdool Karim;Salim S. Abdool Karim;Janet A. Frohlich;Anneke C. Grobler

  3066
  Citations

• HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities.

  Ayesha Bibi Mahomed. Kharsany;Quarraisha. Abdool Karim

  1094
  Citations

• HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

  Viviana Simon;David D Ho;Quarraisha Abdool Karim;Quarraisha Abdool Karim

  1071
  Citations

• Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

  Salim S. Abdool Karim;Kogieleum Naidoo;Anneke Grobler;Nesri Padayatchi

  925
  Citations

• HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

  Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Gavin J. Churchyard;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim;Stephen D. Lawn

  723
  Citations

• Integration of antiretroviral therapy with tuberculosis treatment

  Salim Safurdeen. Abdool Karim;Kogieleum. Naidoo;Anna Christina. Grobler;Nesri. Padayatchi

  644
  Citations

• Adolescent girls and young women: key populations for HIV epidemic control

  Rachael Claire. Dellar;Sarah Alexandra. Dlamini;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim

  546
  Citations

• Genital Inflammation and the Risk of HIV Acquisition in Women

  Lindi Masson;Lindi Masson;Jo Ann S. Passmore;Jo Ann S. Passmore;Lenine J. Liebenberg;Lise Werner

  459
  Citations

• Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women

  Nichole R. Klatt;Ryan. Cheu;Kenzie. Birse;Kenzie. Birse;Alexander S. Zevin

  421
  Citations

• Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

  Unknown

  407
  Citations

• Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

  Penny L. Moore;Elin S. Gray;C. Kurt Wibmer;C. Kurt Wibmer;Jinal N. Bhiman;Jinal N. Bhiman

  382
  Citations

• Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint)

  Pan Hongchao;Richard Peto;Ana-Maria Henao-Restrepo;Marie-Pierre Preziosi

  369
  Citations

• Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

  Unknown

  369
  Citations

• Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis

  Charles S. Morrison;Pai Lien Chen;Cynthia Kwok;Jared M. Baeten

  334
  Citations

• Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study

  Tulio. de Oliveira;Tulio. de Oliveira;Ayesha B. M. Kharsany;Ayesha B. M. Kharsany;Tiago. Gräf;Cherie. Cawood

  321
  Citations

• Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.

  Lindi Roberts;Jo-Ann S Passmore;Carolyn Williamson;Francesca Little

  269
  Citations

• Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

  Salim Safurdeen. Abdool Karim;Angela D. M. Kashuba;Lise. Werner;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim

  259
  Citations

• Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.

  Francois van Loggerenberg;Koleka Mlisana;Carolyn Williamson;Carolyn Williamson;Sara C. Auld;Sara C. Auld

  251
  Citations

• Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.

  Anand. Reddi;Sarah C. Leeper;Anna Christina. Grobler;Rosemary Veronica. Geddes

  249
  Citations

• Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection

  Unknown

  246
  Citations